Skip to content

Insider · CIK 0002045094

Jason S Carter

officer

Files at VERA (Vera Therapeutics, Inc.). First filing Nov 25, 2025, latest Nov 25, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $107k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

VERA: Vera Therapeutics, Inc.

VERAOct 9, 2026 · close 29.88

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
VERAsell 3
Vera Therapeutics, Inc.
$107k
3,864 shares
-7%+51% from low-43% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 21, 2025VERA
Vera Therapeutics, Inc.
SOpen-market sale
Class A Common Stock
-3,864$27.82$107k49,136Nov 25, 2025
Nov 18, 2024VERA
Vera Therapeutics, Inc.
AGrant or award
Class A Common Stock
+53,000$0.00$053,000Nov 20, 2024
Nov 18, 2024VERA
Vera Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+108,000$0.00$0108,000Nov 20, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jason S Carter: insider trades and track record | InsiderTell